نتایج جستجو برای: peptide vaccine

تعداد نتایج: 263016  

Journal: :Journal of Immunology 2023

Abstract The emergence of new virus species or variants poses a major challenge for healthcare systems. Countermeasures, including vaccine development, need to be developed without delay ensure success. Vaccine and antibody development depend on highly efficient tools antigen discovery, epitope mapping, diagnostics (clinical) immune monitoring. Here we present workflow peptide tool that can rap...

Journal: :Molecules 2013
Karla Ramírez-Gualito Monique Richter Manolis Matzapetakis David Singer Stefan Berger

Rational design of peptide vaccines becomes important for the treatment of some diseases such as Alzheimer's disease (AD) and related disorders. In this study, as part of a larger effort to explore correlations of structure and activity, we attempt to characterize the doubly phosphorylated chimeric peptide vaccine targeting a hyperphosphorylated epitope of the Tau protein. The 28-mer linear chi...

Journal: :Vaccine 2004
Connie L Finstad Chang Yi Wang Jacek Kowalski Meilun Zhang Ming Lie Li Xuan Mao Li Wei Guo Xia Maarten C Bosland Krishna K Murthy Alan M Walfield Wayne C Koff Timothy J Zamb

We have designed a peptide-based immunotherapeutic vaccine for treatment of androgen-responsive prostate cancer. The vaccine targets the luteinizing hormone-releasing hormone (LHRH) decapeptide that results in an androgen-deprivation immunotherapy. The design elements of the peptide immunogens are the LHRH peptide or B cell epitope synthetically linked to different promiscuous helper T cell (Th...

2012
Sanghoon Kwon Dongbum Kim Byoung Kwon Park Sunhee Cho Kwang Dong Kim Young-Eun Kim Cheung-Seog Park Hyun-Jong Ahn Jae-Nam Seo Kyung-Chan Choi Doo-Sik Kim Younghee Lee Hyung-Joo Kwon

Although peptide vaccines have been actively studied in various animal models, their efficacy in treatment is limited. To improve the efficacy of peptide vaccines, we previously formulated an efficacious peptide vaccine without carriers using the natural phosphodiester bond CpG-DNA and a special liposome complex (Lipoplex(O)). Here, we show that immunization of mice with a complex consisting of...

2014
Sumiyuki Nishida Shigeo Koido Yutaka Takeda Sadamu Homma Hideo Komita Akitaka Takahara Satoshi Morita Toshinori Ito Soyoko Morimoto Kazuma Hara Akihiro Tsuboi Yoshihiro Oka Satoru Yanagisawa Yoichi Toyama Masahiro Ikegami Toru Kitagawa Hidetoshi Eguchi Hiroshi Wada Hiroaki Nagano Jun Nakata Yoshiki Nakae Naoki Hosen Yusuke Oji Toshio Tanaka Ichiro Kawase Atsushi Kumanogoh Junichi Sakamoto Yuichiro Doki Masaki Mori Toshifumi Ohkusa Hisao Tajiri Haruo Sugiyama

Wilms tumor gene (WT1) protein is an attractive target for cancer immunotherapy. We aimed to investigate the feasibility of a combination therapy consisting of gemcitabine and WT1 peptide-based vaccine for patients with advanced pancreatic cancer and to make initial assessments of its clinical efficacy and immunologic response. Thirty-two HLA-A*24:02 patients with advanced pancreatic cancer wer...

2016
Markus W. Löffler P. Anoop Chandran Karoline Laske Christopher Schroeder Irina Bonzheim Mathias Walzer Franz J. Hilke Nico Trautwein Daniel J. Kowalewski Heiko Schuster Marc Günder Viviana A. Carcamo Yañez Christopher Mohr Marc Sturm Huu-Phuc Nguyen Olaf Riess Peter Bauer Sven Nahnsen Silvio Nadalin Derek Zieker Jörg Glatzle Karolin Thiel Nicole Schneiderhan-Marra Stephan Clasen Hans Bösmüller Falko Fend Oliver Kohlbacher Cécile Gouttefangeas Stefan Stevanović Alfred Königsrainer Hans-Georg Rammensee

BACKGROUND & AIMS We report a novel experimental immunotherapeutic approach in a patient with metastatic intrahepatic cholangiocarcinoma. In the 5year course of the disease, the initial tumor mass, two local recurrences and a lung metastasis were surgically removed. Lacking alternative treatment options, aiming at the induction of anti-tumor T cells responses, we initiated a personalized multi-...

Journal: :The Journal of clinical investigation 2002
Valérie Dutoit Robert N Taub Kyriakos P Papadopoulos Susan Talbot Mary-Louise Keohan Michelle Brehm Sacha Gnjatic Paul E Harris Brygida Bisikirska Philippe Guillaume Jean-Charles Cerottini Charles S Hesdorffer Lloyd J Old Danila Valmori

The cancer-testis antigen NY-ESO-1 is one of the most promising candidates for generic vaccination of cancer patients. Here we analyzed the CD8(+) T cell response to a NY-ESO-1 peptide vaccine composed of the two previously defined peptides 157-165 and 157-167, administered with GM-CSF as a systemic adjuvant. The NY-ESO-1 peptide vaccine elicited a CD8(+) T cell response directed against multip...

Journal: :Archives of otolaryngology--head & neck surgery 2006
Kristin B Gendron Alex Rodriguez Duane A Sewell

OBJECTIVE To test whether an E7 peptide/CpG vaccine is effective in preventing and treating human papillomavirus-positive tumors in a murine model. INTERVENTION First, an E7 peptide/CpG vaccine was administered systemically on days -14 and -7, and tumor cells were injected subcutaneously on day 0. Second, tumor cells were injected on day 0, and vaccine was administered on days 7, 14, and 21. ...

Journal: :Vaccines 2021

Approximately 0.4 billion individuals worldwide are infected with hookworm. An effective vaccine is needed to not only improve the health of those affected and at high risk, but also economic growth in disease-endemic areas. ideal anti-hookworm therapeutic strategy for mass administration a stable orally administered vaccine. Oral vaccines advantageous as they negate need trained medical staff ...

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید